Spine Endoscopy Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 167814.30%
(FY 2023)
- Profit 129554.21%
(FY 2023)
- Net Worth 39719.88%
(FY 2023)
- Total Assets 1606.92%
(FY 2023)
About Spine Endoscopy Research Foundation
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naresh Pagidimarry and Sukumar Sura serve as directors at the Company.
- CIN/LLPIN
U85100TG2020NPL139412
- Company No.
139412
- Company Classification
Private Not For Profit Company
- Incorporation Date
20 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Spine Endoscopy Research Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Pagidimarry  | Director | 20-Feb-2020 | Current |
| Sukumar Sura | Director | 20-Feb-2020 | Current |
Financial Performance of Spine Endoscopy Research Foundation.
Spine Endoscopy Research Foundation, for the financial year ended 2023, experienced significant growth in revenue, with a 167814.3% increase. The company also saw a substantial improvement in profitability, with a 129554.21% increase in profit. The company's net worth Soared by an impressive increase of 39719.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Spine Endoscopy Research Foundation?
In 2023, Spine Endoscopy Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asian Institute Of Spine Endoscopy Private LimitedActive 4 years 11 monthsNaresh Pagidimarry and Sukumar Sura are mutual person
Dnr Medinnovations Private LimitedInactive For E-Filing 8 months 5 daysNaresh Pagidimarry is a mutual person
- Nsure Healthy Spine Private LimitedActive 1 year 8 months
Naresh Pagidimarry and Sukumar Sura are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spine Endoscopy Research Foundation?
Unlock and access historical data on people associated with Spine Endoscopy Research Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spine Endoscopy Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spine Endoscopy Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
